+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Adjuvant radiation therapy for early stage seminoma: proton versus photon planning comparison and modeling of second cancer risk



Adjuvant radiation therapy for early stage seminoma: proton versus photon planning comparison and modeling of second cancer risk



RadioTherapy and Oncology 103(1): 12-17



Given concerns of excess malignancies following adjuvant radiation for seminoma, we evaluated photon and proton beam therapy (PBT) treatment plans to assess dose distributions to organs at risk and model rates of second cancers. Ten stage I seminoma patients who were treated with conventional para-aortic AP-PA photon radiation to 25.5 Gy at Massachusetts General Hospital had PBT plans generated (AP-PA, PA alone). Dose differences to critical organs were examined. Risks of second primary malignancies were calculated. PBT plans were superior to photons in limiting dose to organs at risk. PBT decreased dose by 46% (8.2 Gy) and 64% (10.2 Gy) to the stomach and large bowel, respectively (p<0.01). Notably, PBT was found to avert 300 excess second cancers among 10,000 men treated at a median age of 39 and surviving to 75 (p<0.01). In this study, the use of protons provided a favorable dose distribution with an ability to limit unnecessary exposure to critical normal structures in the treatment of early-stage seminoma. It is expected that this will translate into decreased acute toxicity and reduced risk of second cancers, for which prospective studies are warranted.

(PDF emailed within 0-6 h: $19.90)

Accession: 051383893

Download citation: RISBibTeXText

PMID: 22391053

DOI: 10.1016/j.radonc.2012.01.012


Related references

Predicted rates of secondary malignancies from proton versus photon radiation therapy for stage I seminoma. International Journal of Radiation Oncology, Biology, Physics 82(1): 242-249, 2012

Comparison of Adjuvant Radiation Therapy Alone Versus Radiation Therapy and Endocrine Therapy in Elderly Women With Early-Stage, Hormone Receptor-Positive Breast Cancer Treated With Breast-Conserving Surgery. Clinical Breast Cancer 15(5): 381-389, 2016

Risk of major cardiac events following adjuvant proton versus photon radiation therapy for patients with thymic malignancies. Acta Oncologica 56(8): 1060-1064, 2017

A Comparison of Grade 4 Lymphopenia With Proton Versus Photon Radiation Therapy for Esophageal Cancer. Advances in Radiation Oncology 4(1): 63-69, 2019

Second malignancies after adjuvant radiation therapy for early stage breast cancer: is there increased risk with addition of regional radiation to local radiation?. International Journal of Radiation Oncology, Biology, Physics 91(5): 977-985, 2015

Estimated radiation pneumonitis risk after photon versus proton therapy alone or combined with chemotherapy for lung cancer. Acta Oncologica 50(6): 772-776, 2011

Treatment burden in stage I seminoma: a comparison of surveillance and adjuvant radiation therapy. Bju International 112(8): 1088-1095, 2014

Adjuvant radiation versus observation: a cost analysis of alternate management schemes in early-stage testicular seminoma. Journal of Clinical Oncology 14(11): 2933-2939, 1996

Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early Stage Endometrial Cancer. Journal of Clinical Oncology 2019: Jco1801575, 2019

Predicted Rate of Secondary Malignancies Following Adjuvant Proton Versus Photon Radiation Therapy for Thymoma. International Journal of Radiation Oncology, Biology, Physics 99(2): 427-433, 2017

Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. Journal of Clinical Oncology 18(8): 1606-1613, 2000

Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer: A propensity matched analysis of the relative risk of proton versus photon-based radiation therapy. RadioTherapy and Oncology 128(1): 154-160, 2017

Which technique for radiation is most beneficial for patients with locally advanced cervical cancer? Intensity modulated proton therapy versus intensity modulated photon treatment, helical tomotherapy and volumetric arc therapy for primary radiation - an intraindividual comparison. Radiation Oncology 10: 91, 2016

Intensity modulated proton and photon therapy for early prostate cancer with or without transperineal injection of a polyethylen glycol spacer: a treatment planning comparison study. International Journal of Radiation Oncology, Biology, Physics 84(3): E311-E318, 2012

Relapses in early-stage testicular seminoma: Radiation therapy versus retroperitoneal lymphadenectomy. Scandinavian Journal of Urology & Nephrology 31(4): 355-359, 1997